주요메뉴 바로가기 본문 바로가기

주메뉴

IBS Conferences

Dr. KOO Taeyoung

Research Fellow, Center for Genomic Engineering, IBS, Daejeon, Korea

Education

BS, Kyunghee University (2002)
MS, Younsei University (2005)
PhD, Royal Holloway-University of London, UK (2010)

Major Experience

  • 2010 - 2011 Postdoctoral Research Assistant, Royal Holloway-University of London, UK
  • 2011 - 2014 Postdoctoral Research Scientist, University of Oxford, UK
  • 2012 - 2014 Junior Research Fellow, Somerville College, University of Oxford, UK
  • 2014 - Research Fellow, Center for Genomic Engineering, Institute for Basic Science, Korea

Major Publication

  • Gene Correction of a Duchenne Muscular Dystrophy Mutation by Meganuclease-Enhanced Exon Knock-In, Human Gene Therapy 24 (2013) 692
  • Cell-penetrating peptides having a central hydrophobic domain. Patent number: WO 2013030569 A3 (2013), CA 2846218 A1 (2013), CN 103998458 A (2014), US 20140342992 A1 (2014), EP 2751128 A2 (2014)
  • Triple trans-splicing AAV vectors capable of transferring the coding sequence for full-length dystrophin protein into dystrophic mice, Human Gene Therapy 25(2014) 98
  • Self-assembly induces receptor mediated uptake of therapeutic antisense oligonucleotides Nano Letters (2015)
  • Measuring and Reducing off-target activities of genome-editing nucleases, Molecules and Cells 38 (2015) 475
Research

Are you satisfied with the information on this page?

Content Manager
Human Resources Development Team : Cho Ji-hye   042-878-8136
Last Update 2016-06-24 11:10